Epicrispr Biotechnologies vs Verve Therapeutics
Epicrispr Biotechnologies vs Verve Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Verve Therapeutics on 56/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 56/100
Verve Therapeutics
- domain rating: 53/100 against 40/100
- funding raised: $300M against $90.0M
At a glance
| Measure | Epicrispr Biotechnologies | Verve Therapeutics |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Developing gene editing therapies to lower cholesterol. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Gene Therapy, Cardiovascular Disease, Drug Delivery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2018 |
| Headquarters | South San Francisco, United States | Cambridge, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Verve Therapeutics |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $300M |
| Latest round | Series C | Series D |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Verve Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 56/100 |
| Traction | 57/100 | 40/100 |
| Team | 40/100 | 20/100 |
| Search visibility | 20/100 | 12/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Verve Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Verve Therapeutics: common questions
Which is better, Epicrispr Biotechnologies or Verve Therapeutics?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Verve Therapeutics compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 56/100). Verve Therapeutics leads on domain rating (53/100 against 40/100), funding raised ($300M against $90.0M).
Read the full Epicrispr Biotechnologies review and pricing or the Verve Therapeutics review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.